MedTrace Logo

Evaluating Clinical Acceptance of a NPWT Wound Care System

NCT03670225 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-03-20

No results posted yet for this study

Summary

Determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.

Conditions

  • Diabetic Foot Ulcer
  • Pressure Injury
  • Pressure Ulcer

Interventions

DEVICE

Invia Motion Endure

NPWT Invia Motion Endure

Sponsors & Collaborators

  • Joseph M. Still Research Foundation, Inc.

    collaborator OTHER

  • Medela AG

    lead INDUSTRY

Principal Investigators

  • Robert F Mullins, MD · Joseph M. Still Research Foundation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-16
Primary Completion
2020-01-30
Completion
2020-01-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03670225 on ClinicalTrials.gov